PAR •
Healthcare •
Diagnostics & Research •
Quote as of 07/28/2026 17:35
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangePAR
Market Capitalization7.11 mln
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
386
Highly suspicious
Relative Strength
0
/ 100
Severely lagging
Debt / Equity
-0.84
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Predilife S.A. is a French health company founded in 2004 and based in Villejuif, France, that develops tools to help predict the likelihood of serious diseases before they occur. Its key offerings include MammoRisk, a personalized breast cancer risk test, and DenSeeMammo, a software that measures breast density. The company also provides a broader health screening service covering multiple conditions, as well as Care4Eat, a workplace nutrition program that helps employees understand and improve their eating habits.
